0.5% Lidocaine Hcl Injection, Solution
Product Images NDC 51662-1600

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for 0.5% Lidocaine Hcl (NDC 51662-1600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1600 2 Pouch Labeling)

Label for 0.5% Lidocaine HCl Injection, USP, 5 mg/mL strength, in a 50 mL vial. The label includes NDC 51662-1600, lot and expiration date information, instructions specifying use for infiltration and intravenous regional anesthesia, and notes it is preservative-free. Manufactured by HF Acquisition Co LLC, DBA HealthFirst in Mukilteo, WA.*

FDA Label Image

Case (51662 1600 3 Case Labeling)

Label for 0.5% LIDOCAINE HCl Injection, USP, 250 mg/50 mL (5 mg/mL) 50 mL vial packaged as a case of 25. The label includes the NDC 51662-1600-3, lot number, and expiration date. It identifies the manufacturer as HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA. Usage instructions and storage conditions are printed, noting it is preservative-free and sterile for infiltration and intravenous use.*

FDA Label Image

Serialized Rfid Labeling (51662 1600 3 Sereialized Case Labeling)

Label on a pharmaceutical product showing logistics data including serial numbers and a QR code. It includes text directing to see the manufacturer's package insert, distributed by HF Acquisition Co LLC, DBA HealthFirst in Mukilteo, WA. No visible proprietary or nonproprietary name, strength, or dosage form on this label.*

FDA Label Image

D1 (D1)

Table listing packaging sizes for Lidocaine Injection at various strengths: 1% in 30 mL single-dose teartop vials, 1.5% in 20 mL single-dose ampuls, and 2% in 10 mL single-dose ampuls.*

FDA Label Image

D2 (D2)

A data table titled 'Table 1 Recommended Dosages' for Lidocaine Hydrochloride Injection, USP (without Epinephrine), detailing concentration percentages, volume in mL, and total dose in mg for various procedures. It covers procedures including infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks, with dosage ranges for each procedure type.*

FDA Label Image

Description (Description)

A data table showing concentrations of Lidocaine HCl and sodium chloride for various Lidocaine HCl solution strengths (0.5%, 1%, 1.5%, and 2%). It lists milligrams per milliliter of lidocaine HCl and sodium chloride anhydrous for each concentration level.*

FDA Label Image

Precautions (Precautions)

A data table titled 'Examples of Drugs Associated with Methemoglobinemia' listing drug classes in one column and examples of drugs in the other. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with corresponding examples such as nitric oxide, lidocaine, cyclophosphamide, dapsone, chloroquine, phenobarbital, and acetaminophen.*

FDA Label Image

Logo (Spl Logo)

FDA Label Image

Structure (Structure)

Chemical structure diagram of 0.5% Lidocaine Hydrochloride (Lidocaine HCl), showing the molecular arrangement including benzene ring with two methyl groups, amide group, diethylamine, hydrochloride, and water.*

FDA Label Image

Vial Label (Vial Label)

Label for 0.5% Lidocaine HCl Injection, USP, preservative-free solution with a strength of 250 mg per 50 mL (5 mg/mL) in a 50 mL single-dose vial. Distributed by Hospira, Inc., the label includes administration directions for infiltration and intravenous regional anesthesia, storage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.